Merck to buy Cubist Pharmaceuticals for $8.4 billion
December 08, 2014 at 07:26 AM EST
Merck says it agreed to buy Cubist Pharmaceuticals for $8.4 billion, and the assumptions of $1.1 billion in debt, as it continues with the strategy to narrow its focus on diabetes, acute hospital care, vaccines and oncology.